Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
Ateya, Areej Mohamed; Sabri, Nagwa;
Other data
| Title | Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients | Authors | Ateya, Areej Mohamed; Sabri, Nagwa | Issue Date | 1-Apr-2021 | Journal | Journal of Medical Virology | ISSN | 01466615 | DOI | 10.1002/jmv.26672 | PubMed ID | 33200431 | Scopus ID | 2-s2.0-85096769569 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.